Found: 6
Select item for more details and to access through your institution.
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197372
- By:
- Publication type:
- Article
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.
- Published in:
- Nature, 2009, v. 461, n. 7260, p. 109, doi. 10.1038/nature08268
- By:
- Publication type:
- Article
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.
- Published in:
- Nature Genetics, 2011, v. 43, n. 9, p. 869, doi. 10.1038/ng.890
- By:
- Publication type:
- Article
CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination.
- Published in:
- NAR Cancer, 2023, v. 5, n. 3, p. 1, doi. 10.1093/narcan/zcad039
- By:
- Publication type:
- Article
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158888
- By:
- Publication type:
- Article